Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-003971-38-DE
EUCTR2007-003971-38-DE
Active, Not Recruiting
Phase 1

An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of Montelukast

Merck & Co., Inc.0 sites400 target enrollmentFebruary 21, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsasthma and atopic diseasesMedDRA version: 9.1Level: LLTClassification code 10003560Term: Asthma NOSMedDRA version: 9.1Level: LLTClassification code 10003637Term: Atopic
DrugsSINGULAIR mini 4 mg Granulat

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
asthma and atopic diseases
Sponsor
Merck & Co., Inc.
Enrollment
400
Status
Active, Not Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 21, 2008
End Date
October 28, 2011
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patient successfully completed Visit 8 of Protocol 272\.
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Patient has developed or has been diagnosed with any illness or congenital disorder
  • •that could be immediately life threatening (e.g., arrhythmias congenital heart disease,
  • •brittle diabetes,” neoplasia incompletely cured or treated within the last 3 months),
  • •or would pose a restriction on participation or successful completion of the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of MontelukastEstudio observacional de seguimiento de pacientes pediátricos que participaron en un estudio previo de montelukast en la bronquiolitis inducida por el virus respiratorio sincitial (VRS)
EUCTR2007-003971-38-ESMerck Sharp & Dohme de España, S.A.400
Active, Not Recruiting
Phase 1
An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of Montelukastasthma and atopic diseasesMedDRA version: 9.1 Level: LLT Classification code 10003560 Term: Asthma NOSMedDRA version: 9.1 Level: LLT Classification code 10003637 Term: Atopic
EUCTR2007-003971-38-FRaboratoires Merck Sharp & Dohme - Chibret400
Completed
N/A
Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)Respiratory Syncytial Virus Bronchiolitis
NCT01140048Organon and Co343
Completed
Phase 4
A prospective pediatric longitudinal evaluation to assess the long-term safety of tacrolimus ointment for the treatment of atopic dermatitis.Atopic Dermatitis10014982
NL-OMON30879Astellas Pharma120
Recruiting
N/A
A prospective observational study in child patients with RSV infectioRSV infection
JPRN-jRCT1030230252Ishiwada Naruhiko100